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INTRODUCTION
Pelvic organ prolapse (POP) is a morbid condition
which affects the quality of women life. It has a
high prevalence in developed countries, although
the major etiology is different.1 Failure of the nor-
mal function of levatoranimuscle plays an impor-
tant role in the incident of pelvic organ prolapse in
women.2 The incidence of pelvic organ prolapse on
the anterior wall of vagina was 9.3 cases per 100
women per year, on the posterior wall of the va-
gina about 5.7 cases per 100 women per year, and
uterine prolapse about 1.5 cases per 100 women
per year.3
Little is known about the characteristics of histo-
morphology of the vaginal wall and the changes in
the connective tissue in women with pelvic organ
prolapse. Connective tissue consists of collagen,
elastic fibers and proteoglycans as a major compo-
Abstract
Objectives: To compare the expression of tenascin in the anterior
vaginal wall in women with pelvic organ prolapse and without pelvic
organ prolapse (POP).
Method: This study was a cross sectional study. The study was con-
ducted in RS Dr. Wahidin Sudirohusodo and other network hospitals
of Obstetrics and Gynecology Department of Hasanuddin University,
Makassar, from 1st January 2011 to 1st April 2012. This study as-
sessed the expression of tenascin in 35 women with pelvic organ
prolapse grade III and IV and the controls were 35 women without
pelvic organ prolapse. Tenascin expression was assessed by immu-
nohistochemical examination using tenascin antibody staining
(mouse monoclonal antibody Novacastratenascin C, code NCL-
TenasC). Sampling was done by consecutive sampling. Data proc-
essed by the chi-square. The significance level used was 0.05.
Result: The result of this research shows that with exception of his-
tory of bearing baby > 4000 gr weight (p=0.572); age, parity, meno-
pausal status, and body mass index were significantly different be-
tween the group. This indicates that the variable does not affect the
calculation of research data. While parity, menopausal status and
body mass index (BMI), from an analysis of risk factors for POP were
associated with increased intensity of tenascin is significant in post-
menopausal status, and BMI > 25 (overweight) (p <0.05). Expression
of tenascin in a sample of moderate (+ +) as many as 18 cases
(51.5%) compared with controls expression of tenascin weaker (+)
25 cases (71.5%).
Conclusion: Expression of tenascin robust anterior vaginal wall in
women with POP and weak women without POP.
[Indones J Obstet Gynecol 2013; 1-4: 188-93]
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Abstrak
Tujuan: Membandingkan ekspresi tenascin dinding vagina anterior
pada perempuan dengan prolaps organ panggul dan tanpa prolaps
organ panggul (POP).
Metode: Penelitian ini adalah penelitian potong lintang. Penelitian ini
dilakukan di BLU RS Dr. Wahidin Sudirohusodo dan beberapa rumah
sakit pendidikan bagian obstetric dan ginekologi FK-UNHAS yang
dimulai pada tanggal 1 Januari 2011 sampai 1 April 2012. Penelitian
ini menilai ekspresi tenascin pada 35 perempuan dengan prolaps or-
gan panggul tingkat III dan IV dan sebagai kontrol adalah 35 perem-
puan tanpa prolaps organ panggul. Ekspresi tenascin dinilai dengan
pemeriksaan imunohistokimia menggunakan pewarnaan antibodi
tenascin (Novacastra mouse monoclonal antibody tenascin C, code
NCL-Tenas C). Pengambilan sampel dilakukan secara consecutive
sampling. Data diolah dengan chi-square. Tingkat signifikansi yang
digunakan adalah p=0,05.
Hasil: Hasil penelitian menunjukkan bahwa karakteristik subjek
penelitian berdasarkan usia, pendidikan, paritas, riwayat persalinan,
riwayat melahirkan bayi besar, tidak bermakna secara statistik. Hal
ini menunjukkan bahwa variabel tersebut tidak mempengaruhi perhi-
tungan data penelitian. Sedangkan karakteristik status menopause
dan Indeks Masa Tubuh (IMT), dari analisis faktor risiko terjadinya
POP yang dihubungkan dengan peningkatan intensitas tenascin tam-
pak signifikan pada status postmenopause dan IMT > 25 (overweight)
(p<0,05). Ekspresi tenascin pada sampel moderat (++) sebanyak 18
kasus (51,5%) dibandingkan dengan kontrol ekspresi tenascin yang
lebih lemah (+) sebanyak 25 kasus (71,5%).
Kesimpulan: Ekspresi tenascin-C dinding vagina anterior kuat pada
perempuan dengan POP dan lemah pada perempuan tanpa POP.
[Maj Obstet Ginekol Indones 2013; 1-4: 188-93]
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nent of the extracellular matrix. The main elements
of network stability are quantity, ultrastructure
and organization of protein-extracellular matrix
such as tenascin, elastin, collagen and fibronectin
and their receptors, such as integrins.4
Tenascin is a large glycoprotein, which presents
in the extracellular cells of and involved in mor-
phogenetic movements, tissue pattern formation,
and tissue repair.5 The findings of increased tenas-
cin in the ligament prolapse acceptable due to pel-
vic organ prolapse can be regarded as a form of
tissue trauma. Increased tenascin expression in the
vaginal wall indicates involvement in the healing
process after surgery.6
Several studies have focused on the role of con-
nective tissue and collagen in incidence of poste-
rior vaginal wall prolapse among women.7
Delancey (1992) suggested that the vaginal epithe-
lium, collagen and smooth muscle layers deeper to
provide support along the walls of the vagina and
may be more susceptible to secondary effects of
prolapse.8 Overall, the decrease in immune reacti-
vity increased synthesis of elastin and tenascin
may explain the loss of function of the connective
tissue supporting the uterus. These data indicate
the possible role of these proteins in the patho-
genesis of pelvic organ prolapse as well as provide
an overview of treatment. The research that sup-
port the abnormality structure of connective tissue
or repair mechanism which may predispose
women to suffer from pelvic organ prolapse has
not been done in Indonesia, so with that back-
ground, the research was conducted.
METHODS
This was a cross-sectional study. The data was
processed using SPSS for windows version 17. Chi-
Square or Fisher Exact test and Mann Whitney U-
test was used to compare values of nominal and
scale variable from two or more unpaired groups.
In this case, we compare the expression of tenascin
in pelvic organ prolapse grade III and IV with
women without pelvic organ prolapse.
The research was conducted in the teaching hos-
pital of obstetrics and gynecology Medical Faculty of
Hasanuddin University, Dr. Wahidin Sudirohusodo
Hospital, and other network hospitals as well as labo-
ratory examination of pathology Anatomy Faculty of
Medicine Hasanuddin University. This study was car-
ried out from January 2011 - April 2012.
The study population was women with pelvic
organ prolapse grade (III and IV) who were hospi-
talized and underwent surgery. Samples were
women with severe pelvic organ prolapse grade
(III and IV).
Consecutive sampling conducted, that is, all sub-
jects who meet the criteria for inclusion in the
study were selected. All patients had been pro-
vided informed consent before participating as re-
search subjects. The sample size and the desired
level of accuracy as well as the relative provisions
in accordance with the table of Isaac and Michael.
From this study, a sample of 35 cases of uterine
prolapse grade III and IV, which carried a total of
transvaginal hysterectomy act as a case group, and
35 cases of benign gynecological perabdominal to-
tal hysterectomy as a control group.
Data analysis was performed with Mann-Whit-
ney test to compare the expression of tenascin
between the prolapse and without pelvic organ
prolapse, Chi-Square test and Fisher Exact (if the
expected value of the number of cells in the table
exceeds 20%) to assess homogeneity of charac-
teristics (age, parity, history of surgery, and BMI)
between the two groups, and the level of signifi-
cance used was 0.05 (considered significant if p <0.
05).
RESULTS
In this study, we collected 35 cases of pelvic organ
prolapse grade III and IV, and 35 cases of benign
gynecological tumor as the control group. In Table
1 it appears that the characteristics of patients
most at age > 45 years both in the case of pelvic
organ prolapse and in control. There was no sig-
nificant difference in the average age between the
two groups (p> 0.05).
The group of pelvic organ prolapse is the highest
group who has high level of education = 9 years as
many as 26 people (74.3%), while group without
pelvic organ prolapse as many as 26 people
(74.3%). This difference was not statistically sig-
nificant (p > 0.05).
Most parity on pelvic organ prolapse group is
the child > 3, as many as 28 cases (80.0%), similar
to the group without pelvic organ prolapse is chil-
dren > 3 as many as 19 cases (54.3%). This differ-
ence was not statistically significant (p> 0.05).
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Table 1. The Characteristics of Women with and without
Pelvic Organ Prolapse
Characteristics
Total p
Value
With Prolapse Without Prolapse
n % n %
Age (Years)
≤ 45
> 45
 2
33
 5.7
94.3
 2
33
 5.7
94.3
0.641
Education (Years)
≤ 9
> 9
26
 9
74.3
25.7
26
 9
74.3
25.7
0.767
Parity
0
1 - 2
> 3
 2
 5
28
 5.7
14.3
80.0
 4
12
19
11  
34.3
54.3
0.072
Delivery History
Nullipara
Normal
Vacum
Sectio Caesarian
 2
32
 1
 0
 5.7
29.4
 2.9
 0  
 4
27
 0
 4
11.4
77.1
0  
11.4
0.367
Delivery history of large baby
≤ 3500 gram
> 3500 gram
28
 7
80  
20  
30
 5
85.7
14.3
0.376
Menopausal Status
Premenopause
Menopause
 4
31
11.4
88.6
21
14
60  
40  
0.003
BMI
Normal 18.5-24.99
Obesity > 25.0
11
24
 3.4
68.6
22
13
62.9
37.1
0.008
Chi-squre test, Mann-Whitney p = 0.000 ( p<0.05)
Types of labor history at prolapse group with a
history of pelvic organs are normal delivery ie 32
cases (9.4%), while in the group without pelvic or-
gan prolapse as many as 27 cases (77.1%). This
difference was not statistically significant (p> 0.05).
In the group of pelvic organ prolapse 28 cases
(80.0%) had a history of having a baby > 3,500
grams, while in the group without pelvic organ pro-
lapse as many as 30 cases (85.7%) who had deliv-
ered babies over 3,500 grams. However, this differ-
ence was not statistically significant (p> 0,05).
In the group of pelvic organ prolapse as many
as 31 cases (88.6%) had experienced menopause,
being in the group without pelvic organ prolapse
were 21 cases (60%) have not experienced meno-
pause. This difference was statistically significant
(p < 0.05).
In the group of pelvic organ prolapse as many
as 24 cases (68.6%) have the BMI > 25, while in
the group without pelvic prolapse were 22 cases
(62.9%) had a normal BMI, and only 13 cases
(37.1%) who had BMI > 25. This difference was
statistically significant (p <0.05).
In Table 2 indicates that there are differences in
the expression of tenascin in both cases and con-
trols. Results of Mann-Whitney test to compare be-
tween the two groups showed that in cases of pel-
vic organ prolapse, weak expression of tenascin (+)
there were 11 cases (31.4%), moderate expression
(+ +) of 18 cases (51.5%) and expression of tenas-
cin strong (+ + +) was 6 cases (17.1%). When com-
pared with the group without pelvic organ pro-
lapse, the expression of positive tenascin note with
a weaker expression. In the control group obtained
a weak expression (+) of 25 cases (71.5%), mod-
erate expression of 9 cases (25.7%) and strong ex-
pression (+ + +) 1 (2.8%).
Table 2. Tenascin Expression of Anterior Vagnal Wall
among Women with and without Pelvic Organ Prolapse
Tenascin
Expression
Group
Total
POP Without POP
Mild 11
31.4%
25
71.5%
36
51.5%
Moderate 18
51.5%
 9
25.7%
27
38.5%
Strong  6
17.1%
 1
 2.8%
 7
10%
Total
35
100%
35
100%
70
100%
p=0.000 (p<0.05)
In Table 3, menopausal status was also one of
significant risk factor for the occurrence of pelvic
organ prolapse which is associated with increased
expression of tenascin. In the group of pre-
menopausal pelvic organ prolapse, we found
strong expression of tenascin (+ + +) in 1 case,
moderate (+ +) about 2 cases and weak (+) 1 case.
On postmenopausal women we found strong ex-
pression (+ + +) 17 cases, moderate (+ +) 12 cases
and weak (+) of 2 cases. In contrast to the case
without pelvic organ prolapse in premenopausal
women, it showed weak expression of tenascin (+)
of 16 cases, moderate (+ +) of 4 cases and strong
(+ + +) only 1 case. In the case without pelvic organ
prolapse of postmenopausal women, we found a
weak expression of tenascin (+) 11 cases, moderate
(+ +) as much as 3 cases, and found no cases with
strong tenascin expression (+ + +).
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From the analysis of body mass index (BMI),
BMI ≥ 25 (overweight) was considered as a signifi-
cant risk factor for the occurrence of pelvic organ
prolapse and was also associated with an increased
intensity of tenascin. In the group of pelvic organ
prolapse with normal BMI, we found strong ex-
pression of tenascin (+ + +) in 6 cases, moderate
(+ +) and 2 cases of weak (+) 2 case. In the obese
women found strong expression (+ + +) 11 cases,
moderate (+ +) as many as 13 cases and weak (+)
1 case. In contrast to the case without pelvic organ
prolapse in the normal BMI, showed weak expres-
sion of tenascin (+) 7 cases, moderate (+ +) of 3
cases and strong (+ + +) only one case. In the case
without pelvic organ prolapse obese women found
weak expression of tenascin (+) 10 cases, moderate
(+ +) 1 case, and strong expression of tenascin (+
+ +) of 3 cases.
DISCUSSION
Characteristics of the age group with and without
prolapse reveal the same that is over 45 years old.
In this study, no significant association, but was
positively related due to increased expression of
tenascin in the age group over 45 years.
Mac Lennan et al (2000) concluded that the pel-
vic muscles and pelvic organs ancillary network
tend to decrease in strength along with age. This
is a factor that cannot be avoided.1
Research by Swift et al (2000) showed that  pel-
vic organ prolapse grade I or II occurs mostly in
younger women. Pelvic organ prolapse grade III
and IV of 2.6% turned out to be the most at age >
40 years and the prevalence increased to 21% in
women aged > 70 years. In this study it was found
that there was no difference in age between
women with prolapse grade III, IV and women
Table 3. Risk Factor Analysis of Pelvic Organ Prolapse
Risk Factor
Tenascin Expression
pWith POP Without POP
Weak
(+)
Moderate
(++)
Strong
(+++)
Weak
(+)
Moderate
(++)
Strong
(+++)
Age (Years) 0.641
≤ 45
> 45
0
3
 1
13
 0
18
 0
27
0
7
1
0
Education (Years) 0.767
≤ 9
> 9
3
0
11
 3
12
 6
22
 3
7
3
0
0
Parity 0.072
0
1 - 2
> 3
0
0
3
 1
 2
11
 1
 3
14
 5
 7
16
0
4
2
0
1
0
Delivery History 0.367
Nullipara
Normal
Vacuum
SC
0
3
0
0
 1
13
 0
 0
 1
16
 1
 0
 4
19
 0
 4
0
7
0
0
0
1
0
0
Children Birthweight 0.75
≤ 3500 gram
> 3500 gram
3
0
12
 3
13
 4
23
 4
6
1
1
0
Menopausal Status 0.001
Premenopause
Menopause
1
2
 2
12
 1
17
16
11
4
3
1
0
BMI 0.041
Normal 18.5 - 24.99
Obesity > 25.0
2
1
 2
13
 6
11
 7
10
3
1
1
3
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without pelvic organ prolapse, but age and tenascin
expression was positively related due to increased
tenascin expression in pelvic organ prolapse over
the age of > 45 years.9
Most subjects in both groups had lower educa-
tion (≤ 9 years). In this study the majority of the
sample were housewives with low levels of educa-
tion, in which the characteristics of the group of
pelvic organ prolapse and pelvic organ prolapse
showed non-homogeneous or uniform picture.
Parity was found to be not significant (p> 0.05).
In this study, we found 28 patients (80%) in the
case group with history of childbirth of more than
three times; there were 19 patients (54.3%) his-
tory of childbirth of more than three times in the
control group. Even if it was not statistically sig-
nificant, It could be seen that the incidence of pelvic
organ prolapse was higher in patients with history
of childbirth of more than three times.
This is according to research conducted Chiaf-
farino F et al. who compared between nulliparous
and women with high parity. Women with higher
parity have a higher risk for the occurrence of geni-
tal prolapse (OR 2.6) compared with women who
had never given birth, where OR 3.0 for women
with one vaginal delivery, and 4.5 for women with
2 or more births vaginal.10 The foregoing supports
the hypothesis that vaginal delivery results in sig-
nificant tissue damage proponent which can lead
to weakening of the pelvic floor muscles and pu-
dendal nerve in all women.
History of delivery between the two groups was
not statistically significant. In this study, the inci-
dence of pelvic organ prolapse in patients who un-
derwent vaginal delivery is higher compared with
patients with vaginal delivery without pelvic organ
prolapse.
 The study found no significant association be-
tween infant birth weight > 3,500 g with < 3,500
grams. But the weight of the baby, had a role on
the occurrence of pelvic organ prolapse, which in
this study found that the incidence of pelvic organ
prolapse was higher in infants weighing > 3,500
compared with < 3,500 grams.
The results of this study showed that the ante-
rior vaginal wall in patients with pelvic organ pro-
lapse is characterized by the higher presence of an
immune reaction to tenascin compared to patients
without pelvic organ prolapse. Tenascin expression
in women with moderate pelvic organ prolapse of
+ 2 were found in 18 cases (51.5%), while in
women without pelvic organ prolapse with a
weaker expression of tenascin is +1 as many as 25
cases (71.5%). This is consistent with research on
immune tenascin labeling in the anterior vaginal
wall in women after menopause with and without
pelvic organ prolapse which has been done by
Goepel in 2007 involving 59 women (average age
59-82) who underwent surgery in the Department
of Gynecology, Martin-Luther-University Halle-Wit-
tenberg.11 The results showed that vaginal wall of
prolapse patient is characterized by the presence
of a strong immunolabel whereas in patients with-
out vaginal wall prolapse, the immunolabel was
weaker than prolapse patients.
Tenascin is involved in adhesion, migration, cell
growth and wound healing as well as neovasculari-
zation. Tenascin may be involved both in physi-
ological or pathological functions, depending on
the circumstances and the type of cell as well as
the developmental grade of the organism. The dra-
matic changes also happened in various pathologi-
cal conditions such as tumor, tendon degeneration,
synovitis, colitis, colon adenoma and colorectal car-
cinoma, pathological bone marrow and interstitial
pneumonia.
The pattern of expression changes in tenascin
expression in the anterior vaginal wall at the pro-
lapse occurs because prolapse is a healing phase in
tissue trauma. Trauma itself may have been initi-
ated by various events such as delivery. Lack of es-
trogen after menopause is also likely to have led
to decompensated network.11
Pathophysiology of pelvic organ prolapse in pa-
tients with obesity is the occurrence of increasing
intra-abdominal pressure, resulting in suppression
of the pelvic wall. The pressure of pelvic wall
causes vascularization of the pelvis become worst
and later decrease the muscle tone.
CONCLUSIONS
The expression of tenascin-C in the anterior vaginal
wall among women with pelvic organ prolapse
grade III, IV is stronger than women without pelvic
organ prolapse. In this study, the BMI and meno-
pausal status obtained statistically significant. Fur-
ther research needs to be done at the molecular
level to investigate the pathogenesis of tenascin in
pelvic organ prolapse. This research is expected to
reduce the incidence of pelvic organ prolapse by
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providing counseling to the patients with predis-
posing factors for pelvic organ prolapse.
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